Clinical Trials Browser

Interventional × avelumab × Endocrine × Clear all

NCT04291885 2026-04-09

I-MAT

Phase 2 Active not recruiting

DermatologicEndocrineNET

Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT04261855 2026-03-27

GoTHAM

Phase 1/2 Active not recruiting

DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT03278379 2024-12-24

NET-002

Phase 2 Completed

Neuroendocrine Tumors

NCT03352934 2022-02-25

AveNEC

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT01772004 2021-12-20

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Phase 1 Completed

1,756 enrolled 59 charts

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

NCT03278405 2020-03-18

NET-001

Phase 1/2 Completed

Carcinoma, Neuroendocrine

NCT03147404 2019-12-30

MS100070-0177

Phase 2 Completed

EndocrineLymphoid

Lymphoma, Follicular, Carcinoma, Neuroendocrine